EMVision Medical Devices Limited provided an update on its multi-centre trial. The Company has completed user training at Liverpool Hospital. The administrative "green light" activation has been received, with enrolment and scanning now underway at Liverpool Hospital.

Stage 1 of the trial commences with 30 healthy volunteers, followed by Stage 2 with up to 150 Acute Stroke/Stroke mimic patients. For further details on EMVision's multi-centre trial please see the ASX announcement released on 4th October 2022 titled "Ethics Approval Received For Multi-Centre Clinical Trial". The Company expects to provide updates to the market as it reaches relevant milestones throughout the clinical trial.